Biopharma companies that are involved in the race to develop treatments for COVID-19 are seeing significant changes to their share price . Between January 20 and February 25 , 2020 , Novacyt and Co-Diagnostics saw their share prices surge by around 800 percent and 300 percent , respectively .
